{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CONTROL&page=30", "query": { "intervention": "CONTROL", "page": 30 }, "page_size": 10 }, "pagination": { "page": 30, "page_size": 10, "total_count": 50490, "total_pages": 5049, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CONTROL&page=31&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CONTROL&page=29&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-21T23:57:02.214Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02802319", "title": "Ridge Preservation Following Tooth Extraction Using Porcine and Bovine Xenograft Materials", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Alveolar Bone Loss" ], "interventions": [ { "name": "Porcine Xenograft (Zcore)", "type": "DEVICE" }, { "name": "Bovine Xenograft (Bio-Oss)", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "The University of Texas Health Science Center at San Antonio", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "18 Years to 89 Years" }, "enrollment_count": 44, "start_date": "2016-07", "completion_date": "2018-09", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02802319" }, { "nct_id": "NCT05505565", "title": "Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "PreDiabetes", "Obesity", "Insulin Resistance" ], "interventions": [ { "name": "Abbott Freestyle Libre 2", "type": "DEVICE" }, { "name": "Standard physical activity and nutritional counseling for prediabetes management", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "11 Years", "maximum_age": null, "sex": "ALL", "summary": "11 Years and older" }, "enrollment_count": 54, "start_date": "2023-06-05", "completion_date": "2025-05-15", "has_results": true, "last_update_posted_date": "2026-06-17", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT05505565" }, { "nct_id": "NCT00624065", "title": "Research Study To Test Carvedilol CR + Lisinopril Versus Lisinopril + Placebo In Patients With High Blood Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "carvedilol controlled release/lisinopril", "type": "DRUG" }, { "name": "lisinopril + placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 348, "start_date": "2008-03", "completion_date": "2008-08", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 76, "location_summary": "Mobile, Alabama • Chandler, Arizona • Glendale, Arizona + 66 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Litchifield Park/Arizona", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00624065" }, { "nct_id": "NCT04979767", "title": "Function of Circulating Exosomes in Sepsis-induced Immunosuppression", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Sepsis", "Septic Shock", "Sepsis Syndrome", "Sepsis Bacterial", "Sepsis, Severe", "Sepsis Bacteremia" ], "interventions": [], "intervention_types": [], "sponsor": "University of Kansas Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 80, "start_date": "2021-04-15", "completion_date": "2022-06-30", "has_results": false, "last_update_posted_date": "2021-07-28", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 1, "location_summary": "Kansas City, Kansas", "locations": [ { "city": "Kansas City", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04979767" }, { "nct_id": "NCT01196936", "title": "Low-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer Survivors", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "Tamoxifen Citrate", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Digital mammography", "type": "PROCEDURE" }, { "name": "immunohistochemistry staining method", "type": "OTHER" }, { "name": "pharmacological study", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "protein expression analysis", "type": "GENETIC" }, { "name": "pharmacogenomic studies", "type": "OTHER" }, { "name": "questionnaire administration", "type": "OTHER" }, { "name": "Fine needle aspiration", "type": "PROCEDURE" }, { "name": "Quality of Life Assessment", "type": "OTHER" } ], "intervention_types": [ "DRUG", "PROCEDURE", "OTHER", "GENETIC" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "FEMALE", "summary": "25 Years and older · Female only" }, "enrollment_count": 84, "start_date": "2010-09", "completion_date": "2028-12-11", "has_results": true, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 12, "location_summary": "Birmingham, Alabama • Duarte, California • Aurora, Colorado + 9 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Duarte", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01196936" }, { "nct_id": "NCT02565511", "title": "A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Alzheimers Disease" ], "interventions": [ { "name": "CAD106 Immunotherapy", "type": "BIOLOGICAL" }, { "name": "Placebo to CAD106", "type": "OTHER" }, { "name": "CNP520", "type": "DRUG" }, { "name": "Placebo to CNP520", "type": "OTHER" }, { "name": "Alum", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER", "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "60 Years to 75 Years" }, "enrollment_count": 480, "start_date": "2015-11-30", "completion_date": "2020-04-30", "has_results": true, "last_update_posted_date": "2021-07-08", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 78, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Sun City, Arizona + 67 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02565511" }, { "nct_id": "NCT03885544", "title": "Effects of Consuming Red Meat on the Gut Microbiota in Young Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diet Modification" ], "interventions": [ { "name": "Controlled Lacto-ovo vegetarian diet", "type": "OTHER" }, { "name": "Controlled Unprocessed red meat diet", "type": "OTHER" }, { "name": "Controlled processed red meat diet", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Purdue University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "20 Years", "maximum_age": "35 Years", "sex": "ALL", "summary": "20 Years to 35 Years" }, "enrollment_count": 23, "start_date": "2018-01-09", "completion_date": "2020-03-23", "has_results": false, "last_update_posted_date": "2020-07-14", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 1, "location_summary": "West Lafayette, Indiana", "locations": [ { "city": "West Lafayette", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03885544" }, { "nct_id": "NCT00844844", "title": "Open Label Controlled Trial of Eculizumab in Adolescent Patients With Plasma Therapy-Resistant aHUS", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atypical Hemolytic Uremic Syndrome" ], "interventions": [ { "name": "Eculizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 1, "start_date": "2009-05", "completion_date": "2013-07", "has_results": true, "last_update_posted_date": "2015-07-23", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 6, "location_summary": "Atlanta, Georgia • Fort Wayne, Indiana • New York, New York + 2 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Fort Wayne", "state": "Indiana" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Grapevine", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00844844" }, { "nct_id": "NCT00125164", "title": "Prepubertal Children With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Growth Disorders", "Insulin-Like Growth Factor-1 Deficiency" ], "interventions": [ { "name": "rhIGF-1 (mecasermin, Tercica, Inc.)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ipsen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "3 Years to 12 Years" }, "enrollment_count": 137, "start_date": "2004-03", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2019-09-18", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 1, "location_summary": "Brisbane, California", "locations": [ { "city": "Brisbane", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00125164" }, { "nct_id": "NCT02584309", "title": "Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma, Soft Tissue", "Soft Tissue Sarcoma", "Undifferentiated Pleomorphic Sarcoma", "Leiomyosarcoma", "Liposarcoma", "Synovial Sarcoma", "Myxofibrosarcoma", "Angiosarcoma", "Fibrosarcoma", "Malignant Peripheral Nerve Sheath Tumor", "Epithelioid Sarcoma" ], "interventions": [ { "name": "Dexrazoxane", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Washington University School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73, "start_date": "2016-02-22", "completion_date": "2022-07-17", "has_results": true, "last_update_posted_date": "2023-11-07", "last_synced_at": "2026-10-21T23:57:02.214Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT02584309" } ] }